HOME >> MEDICINE >> NEWS
GSK announces launch of largest ever Phase III trial in lung cancer treatment

Chicago - June 5th, 2007 GlaxoSmithKline (GSK) today announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC). These data were presented at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, [Abstract No: 7554]. Final trial analysis showed a 27% reduction in the relative risk of cancer recurrence following surgery in patients treated with the MAGE-A3 ASCI, compared to placebo.

Final results from this trial confirm the positive interim results released last year at ASCO 2006, and support expanded testing of this novel cancer immunotherapy, said Paul A. Bunn Jr., M.D., James Dudley Endowed Professor of Oncology, Professor of Medicine and Director of the University of Colorado Cancer Center, Aurora, Colorado. This approach represents a potentially momentous shift in the cancer treatment paradigm. I believe we have only just scratched the surface of what is possible and look forward to seeing the results of the Phase III trial in due course.

Based on these encouraging data, GSK also announced today the opening of patient recruitment to the randomized and controlled Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MAGE-A3 positive patients with completely resected stage IB, II or IIIA NSCLC.

GSKs ASCIs aim to stimulate the patients own immune response to identify and attack cancer cells in a highly specific manner. This novel cancer immunotherapy is developed using tumor specific antigens, delivered as highly purified recombinant proteins, and GSKs own proprietary Adjuvant Systems, which are specifically designed to enhance ASCIs anti-tumor activity

Phase
'"/>

Contact: Andrea Long
andreal@wagged.com
202-326-0791
GlaxoSmithKline Biologicals
5-Jun-2007


Page: 1 2 3

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. AstraZeneca announces SYMBICORT is now available in the US
3. Weill Cornell Medical College announces gifts totaling $400M
4. Elsevier announces launch of Brain Stimulation
5. NSW Premier announces $15M for childrens cancer research
6. National Inventors Hall of Fame announces 2007 inductees
7. Emory University announces new Global Health Institute
8. BioMed Central announces Journal of Medical Case Reports
9. Tibotec Therapeutics announces start of largest US study on HIV treatment in women
10. Wiley announces partnership with NASPGHAN and AASLD
11. W.M. Keck Foundation announces 2006 class of Distinguished Young Scholars in Medical Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... TORONTO (PRWEB) , ... October 16, 2018 , ... dicentra ... Cannabis Edibles HACCP Certification Program . Canada will become the first G7 country ... 2019, the government of Canada also plans to formally legalize the production and use ...
(Date:10/16/2018)... ... October 16, 2018 , ... AutismOne, the nation’s largest and ... the 4th Annual International HPV Vaccine Education Symposium. , Presenters from countries around ... through Friday, May 24, 2019, with a keynote address from Robert F. Kennedy, ...
(Date:10/13/2018)... ... ... This World Food Day – Tuesday, October 16 – Rise Against Hunger ... by breaking a GUINNESS WORLD RECORDS title with volunteers around the globe. The organization ... international locations together to break the GUINNESS WORLD RECORDS title for the Most people ...
(Date:10/11/2018)... ... 2018 , ... Four weeks before the November 2018 election, ... Department of Homeland Security deputy assistant secretary Paul Rosenzweig in a new online ... , Pointing to the ability of Russian hackers to gain access to 75,000 ...
(Date:10/6/2018)... ... 06, 2018 , ... Jose Rodriguez- Feliz M.D is a ... Beauty, well known for their exclusivity, and luxurious lifestyle publication is privileged to ... addition to the Haute Living network. , Haute Beauty consists of a ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... ... October 11, 2018 , ... In the last four months it has also ... and allowance of six more in USA, China and Japan from three other patent ... safety and security products. , The patents assigned from QinetiQ include US 7113092, titled ...
(Date:10/7/2018)... , ... October 07, 2018 , ... No one likes to think about an emergency, ... can be disruptive to a family. The local ServPro professional, a trusted leader in the ... shocks of an emergency. , No time is a good time for an emergency, ...
(Date:10/6/2018)... , ... October 06, 2018 , ... The global wellness ... 2015 to $4.2 trillion in 2017, according to an in-depth research report, the ... (GWI). This all-new data on the ten markets that comprise the global wellness economy ...
Breaking Medicine Technology:
Cached News: